DCF Valuation Model for Invex Therapeutics, page-150

Everything on the ASX speculative front is a gamble. Buying into a mining company trying to find gold/silver/copper/lithium is a gamble. Buying into a SAAS company hoping they sign the next big revenue deal etc. Biotech companies are the exact same, however risk is minimized if you can buy at a point of time where the company is at ground zero, and the market is valuing it next to nothing. Unlike alot of other biotech companies out there which may have a larger TAM or more indications, they are miles away from the final product, considering they may be in phase 1 or 2 trials still, they will need to conduct multiple raises throughout the many years of trials to there leading product. IXC although only the 1 indication has already raised the sufficient cash to go all the way, they are in phase 3 trials, they have a time line and are full steam ahead. Yes its risky of course, like all the asx speculative stocks out there, but considering what NEU has done, what CUV has done (both billion dollar companies now), why wouldnt you have a shot at IXC and potential have a 20 bagger plus investment paying dividends in 5 years time. IXCs risk level done here is very minimal. Like I said earlier there is no way leading up to results the market is going to be valuing this company anything less than 150 million MC considering upon success it opens up access to a 1 billion TAM plus and even further with potential FDA review. There phase 2 results are impressive.

Worst case scenario down here you buy now, sell half leading up to results to fully de-risk your investment and free carry into phase 3 results.

I bet you people holding NEU and CUV back in the days were saying the same thing. Now alot of them are millionaires, holding 15-20 bag stock which is consistently generating revenue and profit and paying dividends. Got to ask yourself, how often do these gifts come along in a lifetime? Majority of these ASX companies, especially cease to exist pass phase 1 let alone phase 2. This one has a chance of going all the way, and you get to buy it at IPO level... DYOR